Stocks · News reference
Integra LifeSciences shares are trading lower. The company reported Q2 financial results and lowered its FY26 sales guidance.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Raises Price Target to $18
8-K filing — INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
Filed: 2026-07-29 AccNo: 0000917520-26-000055 Size: 427 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits